The prevalence of Alzheimer’s disease continues to spread as families age, but its root cause remains unknown, and prevention and treatment remain uncertain.
New evidence points to an unexpected suspect: a common respiratory disease infection That may shape changes in the brain.
Approximately 7.2 million older adults in the United States alone have Alzheimer’s disease dementia In 2025, scientists still don’t know what causes the disease in the first place.
Possible factors
Chlamydia pneumoniae This is a pneumonia bacterium that appears in some Alzheimer’s disease brain samples and will be released in 2024. review Appraised the evidence.
researchers Cedars-Sinai Medical Center We integrated human tissue studies, animal experiments, and cell studies to map possible connections.
The study was led by Maya Koronyo-Hamaoui, MD, of the Department of Neurosurgery at Cedars-Sinai University.
Because her research focuses on immune stress in brain and eye tissues, this review treats infection as a contributing factor rather than the sole cause.
persistent infection
Microbiologists tracked down how it works. Chlamydia pneumoniaeor Cp, spreads by entering the cell.
They switch between tough locomotor and growth forms, and this switch helps them survive antibiotic and immune attacks.
Under pressure, Cp slows down and can remain in the host’s body for months. cellThis makes detection and treatment more difficult.
This kind of persistence is important in an aging body, and repeated respiratory infections can keep the same inflammatory signals coming back.
Pathway to brain tissue
For Cp to become a problem in dementia, it must reach the brain, or at least go far beyond the lungs and interfere with the immune system.
Researchers have proposed nasal and blood routes, both of which could transport Cp to brain tissue.
Infected immune cells can spread the infection by slipping through the blood-brain barrier, a cell wall that controls entry into the brain.
Nasal infections can also affect nearby nerves, but researchers still debate how often it occurs in people.
Clues from patient brains
Postmortem donated brain tissue provides the clearest hints about Alzheimer’s disease because researchers can directly examine the bacterial material.
In 1998, report described Cp, a brain region that also exhibits classic Alzheimer’s disease lesions.
Some experts have found Cp inside neurons and immune-like cells, sometimes near clumps of protein that are characteristic of the brains of Alzheimer’s patients.
Other laboratories did not detect any Cp, keeping the evidence correlated and sensitive to methodology and sampling.
What we learned from animal experiments
The researchers went beyond human samples by infecting mice through the nose and observing changes in their brains afterwards.
2004 study We found Alzheimer-like amyloid plaques in the brains of mice after experimental nasal Cp infection.
These plaques contain amyloid beta, a sticky protein fragment that can clump together, but the mouse timeline doesn’t match human aging.
Additionally, many models do not measure memory or reasoning, and their association with cognitive decline remains untested.
Proteins respond to infections
Some scientists now consider amyloid beta not only as a waste product in Alzheimer’s disease, but also as part of the immune response.
in 2016 paperresearchers reported that amyloid beta can trap some microorganisms, and that this may require amyloid beta to aggregate.
If the brain continues to sense an infection, amyloid beta may continue to be produced, and the clumps may become harder to remove over time.
Although this logic is consistent with the infection hypothesis, it is not yet clear whether the bacteria cause disease or simply collect in damaged tissue.
Inflammation can cause damage
Even if bacteria aren’t growing in large numbers, your immune system can damage neurons if it’s turned on for too long.
Infected cells release cytokines, small messenger proteins that call back immune cells, and those signals can leak into the body. brain.
The brain’s resident immune cells respond by changing shape, producing toxic molecules, and sometimes failing to efficiently remove amyloid beta.
This type of collateral damage can promote degeneration, which may depend on age, genetics, and strength of infection.
Genes may modulate Alzheimer’s disease risk
The main genetic risk factors for Alzheimer’s disease come from: APOE4genetic variants. Experimental data suggests that APOE4 may change how cells process fats, allowing some microorganisms to use those fats to grow.
The researchers also linked APOE4 to increased Cp load in brain tissue, which may amplify immune stress.
Genetics may not start an infection, but it can set the conditions that determine whether an exposure leaves lasting damage.
Future research directions
To move from suspicion to evidence, scientists need studies that follow people over time and track markers of infection.
“No definitive studies have been conducted to prove or disprove the role of Cp as a causative or facilitator in Alzheimer’s disease pathology and cognitive decline,” writes Dr. Koronyo-Hamaoui.
Teams need to standardize organization Because small choices in sampling, genetic testing, and detection tools can flip a sample from positive to negative.
Until these results are available, doctors should not use antibiotics to prevent dementia. Because the unproven benefits may outweigh the harm.
Taken together, these evidences suggest that Cp may act as a facilitator in the sensitive brain by maintaining inflammation and amyloid production.
The review also highlights how much uncertainty remains and points to careful, long-term studies that can resolve cause and effect.
This study Frontiers of neuroscience.
—–
Like what you read? Subscribe to newsletter We bring you fascinating articles, exclusive content, and the latest updates.
Please check it out earth snapThis is a free app provided by. Eric Ralls and Earth.com.
—–